98 related articles for article (PubMed ID: 9143693)
1. Leukocyte protein tyrosine kinases: potential targets for drug discovery.
Bolen JB; Brugge JS
Annu Rev Immunol; 1997; 15():371-404. PubMed ID: 9143693
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine kinases: structure, substrate specificity, and drug discovery.
al-Obeidi FA; Wu JJ; Lam KS
Biopolymers; 1998; 47(3):197-223. PubMed ID: 9817025
[TBL] [Abstract][Full Text] [Related]
3. Redox control of catalytic activities of membrane-associated protein tyrosine kinases.
Nakashima I; Takeda K; Kawamoto Y; Okuno Y; Kato M; Suzuki H
Arch Biochem Biophys; 2005 Feb; 434(1):3-10. PubMed ID: 15629102
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
5. Src homology-2 domains: structure, mechanisms, and drug discovery.
Sawyer TK
Biopolymers; 1998; 47(3):243-61. PubMed ID: 9817027
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease.
Force T; Kuida K; Namchuk M; Parang K; Kyriakis JM
Circulation; 2004 Mar; 109(10):1196-205. PubMed ID: 15023894
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction: multiple pathways, multiple options for therapy.
Heldin CH
Stem Cells; 2001; 19(4):295-303. PubMed ID: 11463949
[TBL] [Abstract][Full Text] [Related]
8. Development of inhibitors for protein tyrosine kinases.
Al-Obeidi FA; Lam KS
Oncogene; 2000 Nov; 19(49):5690-701. PubMed ID: 11114749
[TBL] [Abstract][Full Text] [Related]
9. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
Verkhivker GM
Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
[TBL] [Abstract][Full Text] [Related]
10. T-cell-targeted signaling inhibitors.
Won J; Lee GH
Int Rev Immunol; 2008; 27(1-2):19-41. PubMed ID: 18300054
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases.
Thomas ML
Semin Immunol; 1995 Aug; 7(4):279-88. PubMed ID: 8520032
[TBL] [Abstract][Full Text] [Related]
12. Chemical approaches to reversible protein phosphorylation.
Cole PA; Courtney AD; Shen K; Zhang Z; Qiao Y; Lu W; Williams DM
Acc Chem Res; 2003 Jun; 36(6):444-52. PubMed ID: 12809531
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of the tyrosine kinase signaling cascade for asthma.
Wong WS
Curr Opin Pharmacol; 2005 Jun; 5(3):264-71. PubMed ID: 15907913
[TBL] [Abstract][Full Text] [Related]
14. Src kinase-mediated signaling in leukocytes.
Korade-Mirnics Z; Corey SJ
J Leukoc Biol; 2000 Nov; 68(5):603-13. PubMed ID: 11073097
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
Son MY; Kim J; Han HW; Woo SM; Cho YS; Kang YK; Han YM
Reproduction; 2008 Oct; 136(4):423-32. PubMed ID: 18583472
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction through the IL-4 and insulin receptor families.
Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH
Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895
[TBL] [Abstract][Full Text] [Related]
17. Janus tyrosine kinases and signal transducers and activators of transcription regulate critical functions of T cells in allograft rejection and transplantation tolerance.
Stepkowski SM; Kirken RA
Transplantation; 2006 Aug; 82(3):295-303. PubMed ID: 16906023
[TBL] [Abstract][Full Text] [Related]
18. Leukocytes express a novel gene encoding a putative transmembrane protein-kinase devoid of an extracellular domain.
Ben-Neriah Y; Bauskin AR
Nature; 1988 Jun; 333(6174):672-6. PubMed ID: 2836739
[TBL] [Abstract][Full Text] [Related]
19. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R; Mora LB; Jove R
Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
[TBL] [Abstract][Full Text] [Related]
20. Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases.
Quinn JC; Johnson-Farley NN; Yoon J; Cowen DS
J Pharmacol Exp Ther; 2002 Nov; 303(2):746-52. PubMed ID: 12388661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
